| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | paclitaxel | UHNBreast | pan-cancer | AAC | -0.31 | 0.3 |
| mRNA | BRD9876:MK-1775 (4:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.12 | 0.3 |
| mRNA | CAY10594 | CTRPv2 | pan-cancer | AAC | 0.037 | 0.3 |
| mRNA | pifithrin-alpha | CTRPv2 | pan-cancer | AAC | 0.036 | 0.3 |
| mRNA | IPR-456 | CTRPv2 | pan-cancer | AAC | 0.036 | 0.4 |
| mRNA | necrostatin-1 | CTRPv2 | pan-cancer | AAC | 0.035 | 0.4 |
| mRNA | PDMP | CTRPv2 | pan-cancer | AAC | 0.036 | 0.4 |
| mRNA | BRD-K99584050 | CTRPv2 | pan-cancer | AAC | 0.049 | 0.4 |
| mRNA | BIRB 0796 | CTRPv2 | pan-cancer | AAC | 0.035 | 0.4 |
| mRNA | Erlotinib | gCSI | pan-cancer | AAC | -0.053 | 0.4 |